Tesamorelin (10mg)

Tesamorelin 10mg, an FDA-approved GHRH analogue for GH axis research. Purity verified at a Top Australian University. Fast Australian shipping.

Tesamorelin is a growth hormone releasing hormone analogue consisting of human GHRH(1-44) with a trans-3-hexenoic acid modification at the N-terminus. Developed by Theratechnologies, it was FDA-approved in 2010 under the brand name Egrifta, making it one of the few GHRH peptides with regulatory approval.

Unlike Sermorelin which contains only the first 29 amino acids, Tesamorelin includes the full 44-amino acid GHRH sequence. The trans-3-hexenoic acid modification at the N-terminus provides enhanced stability against enzymatic degradation while maintaining full GHRH receptor binding activity.